comparemela.com

Page 12 - Devices Agency News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Robust Recovery: BridgeBio (BBIO) Shares Soar After-Market

An impressive rebound in BridgeBio (BBIO) stock, fueled by strategic collaborations, marking a resilient uptrend in after-market trading.

News Highlights: February 14, 2024

News Highlights: February 14, 2024
malaya.com.ph - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaya.com.ph Daily Mail and Mail on Sunday newspapers.

Marcos OKs pharma-zones for cheaper generics

Marcos OKs pharma-zones for cheaper generics
philstar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from philstar.com Daily Mail and Mail on Sunday newspapers.

BridgeBio sells partial rights to dwarfism drug for $100M

The upfront payment pads BridgeBio’s balance sheet as the company gears up for the anticipated launch of another drug, ATTR-CM med acoramidas.

BridgeBio Pharma (BBIO) and Kyowa Kirin Partner $100M Upfront Payment for Exclusive License on Infigratinib in Skeletal Dysplasias in Japan

BridgeBio Pharma (BBIO) and Kyowa Kirin Partner $100M Upfront Payment for Exclusive License on Infigratinib in Skeletal Dysplasias in Japan
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.